• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的多囊卵巢综合征女性与正常女性血清苗勒管抑制物质与其他生殖激素之间的关系

Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women.

作者信息

Cook Christine L, Siow Yong, Brenner Amy G, Fallat Mary E

机构信息

Department of Obstetrics and Gynecology, University of Louisville, Louisville, Kentucky 40292, USA.

出版信息

Fertil Steril. 2002 Jan;77(1):141-6. doi: 10.1016/s0015-0282(01)02944-2.

DOI:10.1016/s0015-0282(01)02944-2
PMID:11779604
Abstract

OBJECTIVE

To examine the relationship of serum müllerian-inhibiting substance (MIS), E(2), free-T, LH, and FSH in untreated women with polycystic ovary syndrome (PCOS) and in women with normal menstrual cycles.

DESIGN

A prospective study.

SETTING

University Departments of Obstetrics and Gynecology and Surgery.

PATIENT(S): Twenty-seven women with PCOS and 20 women with normal menstrual cycles.

INTERVENTION(S): Serum was collected from women with PCOS and from normal women during the early follicular phase of the menstrual cycle, stored frozen until assayed.

MAIN OUTCOME MEASURE(S): Serum levels of MIS, E(2), free-T, TSH, LH, and FSH were measured.

RESULT(S): Serum müllerian-inhibiting substance levels in PCOS patients were significantly higher compared with normal women (+/- SE; 5.3 +/- 0.7 and 1.4 +/- 0.2 ng/mL, respectively). An inverse correlation (r = -0.5965) was found between serum levels of MIS and E(2) in PCOS women, but not in normal women. Women with PCOS had higher serum LH levels than those of normal women (15.2 +/- 1.2 and 5.0 +/- 0.7 mIU/mL).

CONCLUSION

In this study, women with PCOS have significantly higher serum MIS levels than normal women. The inverse relationship between müllerian-inhibiting substance and E(2) levels suggests that MIS may modulate ovarian E(2) synthesis and have a role in the disordered folliculogenesis characteristic of PCOS.

摘要

目的

研究未经治疗的多囊卵巢综合征(PCOS)女性及月经周期正常女性血清苗勒管抑制物质(MIS)、雌二醇(E₂)、游离睾酮(free - T)、促黄体生成素(LH)和促卵泡生成素(FSH)之间的关系。

设计

一项前瞻性研究。

地点

大学妇产科和外科系。

患者

27例PCOS女性和20例月经周期正常的女性。

干预措施

在月经周期的卵泡早期从PCOS女性和正常女性中采集血清,冷冻保存直至检测。

主要观察指标

检测血清MIS、E₂、free - T、促甲状腺激素(TSH)、LH和FSH水平。

结果

PCOS患者血清苗勒管抑制物质水平显著高于正常女性(±标准误;分别为5.3±0.7和1.4±0.2 ng/mL)。PCOS女性血清MIS水平与E₂之间存在负相关(r = -0.5965),而正常女性中未发现此相关性。PCOS女性血清LH水平高于正常女性(15.2±1.2和5.0±0.7 mIU/mL)。

结论

在本研究中,PCOS女性血清MIS水平显著高于正常女性。苗勒管抑制物质与E₂水平之间的负相关表明,MIS可能调节卵巢E₂合成,并在PCOS特征性的卵泡发育异常中起作用。

相似文献

1
Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women.未经治疗的多囊卵巢综合征女性与正常女性血清苗勒管抑制物质与其他生殖激素之间的关系
Fertil Steril. 2002 Jan;77(1):141-6. doi: 10.1016/s0015-0282(01)02944-2.
2
Serum Müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome.月经周期正常或患有多囊卵巢综合征的青春期女孩血清苗勒管抑制物质水平
Fertil Steril. 2005 Oct;84(4):938-44. doi: 10.1016/j.fertnstert.2005.02.052.
3
Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.苗勒管抑制物质比抑制素B能更好地反映多囊卵巢综合征女性的卵巢情况。
Fertil Steril. 2005 Dec;84(6):1685-8. doi: 10.1016/j.fertnstert.2005.06.026.
4
[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[多囊卵巢综合征女性与育龄期健康女性的血清抗苗勒管激素水平]
Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23.
5
Serum müllerian-inhibiting substance levels during normal menstrual cycles.
Fertil Steril. 2000 Apr;73(4):859-61. doi: 10.1016/s0015-0282(99)00639-1.
6
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.血清抗苗勒管激素水平在育龄后期之前一直保持较高水平,而在多囊卵巢综合征女性接受二甲双胍治疗期间会下降。
Hum Reprod. 2005 Jul;20(7):1820-6. doi: 10.1093/humrep/deh850. Epub 2005 Mar 31.
7
Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.卵泡液和血清中的苗勒管抑制物质:输卵管因素不孕、多囊卵巢综合征和子宫内膜异位症患者的比较。
Fertil Steril. 1997 May;67(5):962-5. doi: 10.1016/s0015-0282(97)81417-3.
8
Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.在多囊卵巢综合征患者和正常女性中,急性注射促卵泡激素不会改变血清抗苗勒管激素浓度。
J Clin Endocrinol Metab. 2007 May;92(5):1871-4. doi: 10.1210/jc.2006-2425. Epub 2007 Feb 13.
9
Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.血清抗苗勒管激素水平升高可作为多囊卵巢综合征的一种新的诊断标志物。
Acta Obstet Gynecol Scand. 2013 Dec;92(12):1369-74. doi: 10.1111/aogs.12247. Epub 2013 Oct 15.
10
Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.
Fertil Steril. 2004 Oct;82(4):970-2. doi: 10.1016/j.fertnstert.2004.06.001.

引用本文的文献

1
Evaluation of the incidence of congenital uterine anomalies in polycystic ovarian syndrome: tertiary center experience.多囊卵巢综合征中先天性子宫异常发生率的评估:三级中心经验
Front Med (Lausanne). 2025 May 22;12:1582100. doi: 10.3389/fmed.2025.1582100. eCollection 2025.
2
Unveiling lipoprotein subfractions signature in high-FNPO PCOS: implications for PCOM diagnosis and risk assessment using advanced machine learning models.揭示高游离脂肪酸多囊卵巢综合征患者的脂蛋白亚组分特征:对使用先进机器学习模型进行多囊卵巢形态诊断和风险评估的意义。
BMC Med. 2025 May 19;23(1):289. doi: 10.1186/s12916-025-04120-z.
3
Evaluation of Biochemical Serum Markers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Obese Women in Kazakhstan: Is Anti-Müllerian Hormone a Potential Marker?
哈萨克斯坦肥胖女性多囊卵巢综合征(PCOS)诊断中生化血清标志物的评估:抗苗勒管激素是一种潜在标志物吗?
Biomedicines. 2024 Oct 14;12(10):2333. doi: 10.3390/biomedicines12102333.
4
Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?抗苗勒管激素是多囊卵巢综合征患者卵泡液氧化应激的替代指标吗?
Front Cell Dev Biol. 2024 Jul 1;12:1408879. doi: 10.3389/fcell.2024.1408879. eCollection 2024.
5
Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review.多囊卵巢综合征中的抗苗勒管激素与生育治疗决策:文献综述
J Hum Reprod Sci. 2024 Jan-Mar;17(1):16-24. doi: 10.4103/jhrs.jhrs_153_23. Epub 2024 Mar 28.
6
Age-related Curves of AMH Using the Gen II, the picoAMH, and the Elecsys Assays in Women With Polycystic Ovary Syndrome.多囊卵巢综合征女性中使用第二代检测法、超敏抗缪勒管激素检测法和电化学发光免疫分析法的抗缪勒管激素(AMH)与年龄相关曲线
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2561-2570. doi: 10.1210/clinem/dgae153.
7
Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review.多囊卵巢综合征(PCOS)的病理生理学和营养方法:全面综述。
Curr Nutr Rep. 2023 Sep;12(3):527-544. doi: 10.1007/s13668-023-00479-8. Epub 2023 May 22.
8
Current Guidelines for Diagnosing PCOS.多囊卵巢综合征的现行诊断指南。
Diagnostics (Basel). 2023 Mar 15;13(6):1113. doi: 10.3390/diagnostics13061113.
9
Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.多囊卵巢综合征(PCOS)妇女与非 PCOS 妇女循环中抗苗勒管激素和雄激素形式的变化:一项贯穿整个孕期的系统纵向研究。
Hum Reprod. 2023 May 2;38(5):938-950. doi: 10.1093/humrep/dead050.
10
Markers of ovarian reserve as predictors of future fertility.卵巢储备标志物预测未来生育能力。
Fertil Steril. 2023 Jan;119(1):99-106. doi: 10.1016/j.fertnstert.2022.10.014. Epub 2022 Nov 29.